• Users Online: 339
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Apixaban versus Warfarin in Patients with Left Ventricular Thrombus: A Pilot Prospective Randomized Outcome Blinded Study Investigating Size Reduction or Resolution of Left Ventricular Thrombus

W. Isa W Yus Haniff, Hwong Niny, Mohamed Yusof Ahmad Khairuddin, Yusof Zurkurnai, Loong Ng Seng, Wan-Arfah Nadiah, Naing Nyi Nyi

Year : 2020| Volume: 9| Issue : 4 | Page no: 150-154

   This article has been cited by
 
1 Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials
Anders Olof Sahlén, Haowen Jiang, Yee How Lau, Lucky Cuenza, F. Aaysha Cader, Mohammed Al-Omary, Purich Surunchupakorn, Ka Hei Ho, Jonathan Sung, Derek Lee, Satoshi Honda, Jack Tan Wei Chieh, Jonathan Yap
The Journal of Clinical Pharmacology. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
A. D. Aga, A. A. Sokolova, D. A. Napalkov
Rational Pharmacotherapy in Cardiology. 2023; 18(6): 727
[Pubmed]  [Google Scholar] [DOI]
3 Direct oral anticoagulants versus vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis
Francesco CONDELLO, Matteo MAURINA, Mauro CHIARITO, Matteo STURLA, Riccardo TERZI, Fabio FAZZARI, Jorge SANZ-SANCHEZ, Francesco CANNATA, Gianluigi CONDORELLI, Giulio G. STEFANINI
Minerva Cardiology and Angiology. 2023; 70(6)
[Pubmed]  [Google Scholar] [DOI]
4 Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
Minerva Codruta Badescu, Victorita Sorodoc, Catalina Lionte, Anca Ouatu, Raluca Ecaterina Haliga, Alexandru Dan Costache, Oana Nicoleta Buliga-Finis, Ioan Simon, Laurentiu Sorodoc, Irina-Iuliana Costache, Ciprian Rezus
Journal of Personalized Medicine. 2023; 13(1): 158
[Pubmed]  [Google Scholar] [DOI]
5 Novel subgroups of patients with left ventricular thrombus and their differential effects with anticoagulation: a data-driven cluster analysis (Preprint)
Boqun Shi, Rui Zhang, Chenxi Song, Kongyong Cui, Dong Zhang, Qiuting Dong, Lei Jia, Dong Yin, Hongjian Wang, Ke-Fei Dou, Weihua Song
Journal of Medical Internet Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
6 Apixaban in Patients with Post-Myocardial Infarction Left Ventricular Thrombus: A Randomized Clinical Trial
Ali A. Youssef, Mustafa A. Alrefae, Hesham H. Khalil, Hisham I. Abdullah, Zizi S. Khalifa, Amani A. Al Shaban, Hammam A. Wali, Mazen R. AlRajab, Omar M. Saleh, Baher N. Nashy
CJC Open. 2022;
[Pubmed]  [Google Scholar] [DOI]
7 Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
Glenn N. Levine, John W. McEvoy, James C. Fang, Chinwe Ibeh, Cian P. McCarthy, Arunima Misra, Zubair I. Shah, Chetan Shenoy, Sarah A. Spinler, Srikanth Vallurupalli, Gregory Y.H. Lip
Circulation. 2022; 146(15)
[Pubmed]  [Google Scholar] [DOI]
8 Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
Lei Huang, Yuan Tan, Yilong Pan
ESC Heart Failure. 2022;
[Pubmed]  [Google Scholar] [DOI]
9 Are direct oral anticoagulants preferable to warfarin for the treatment of left ventricular thrombi? A Bayesian meta-analysis of randomized controlled trials
Ahmed Sayed, Mohanad Ghonim, Mohamed Ghonim, Ahmed K. Awad, Yehia Saleh, Omar M. Abdelfattah
American Heart Journal Plus: Cardiology Research and Practice. 2021; 12: 100066
[Pubmed]  [Google Scholar] [DOI]
10 An updated review of the efficacy and safety of direct oral anticoagulants in treatment of left ventricular thrombus
Kevin A. Honan,Arjun Jogimahanti,Tarif Khair
The American Journal of Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article